How mitochondrial function affects inflammation in Alzheimer's disease
Mitochondrial modulation of neuroinflammation in AD and related tauopathies
This study is looking at how problems with energy production in cells and inflammation in the brain might affect Alzheimer's disease, and it's testing a special protein that could help protect brain cells and slow down memory loss.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-10766083 on NIH RePORTER |
What this research studies
This research investigates the role of mitochondrial dysfunction and neuroinflammation in Alzheimer's disease (AD) and related tauopathies. It focuses on understanding how these two factors interact and contribute to the progression of cognitive impairment. The study utilizes animal models to explore the effects of overexpressing a specific mitochondrial protein, Mfn2, which has shown promise in reducing tau phosphorylation and associated neuronal damage. By examining these mechanisms, the research aims to identify potential therapeutic targets for AD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related tauopathies.
Not a fit: Patients with other forms of dementia that do not involve tau pathology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that slow down or prevent cognitive decline in Alzheimer's disease patients.
How similar studies have performed: Previous studies have shown that targeting mitochondrial function and neuroinflammation can be effective in animal models of neurodegenerative diseases, suggesting a promising avenue for further exploration.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Wang, Xinglong — University of Arizona
- Study coordinator: Wang, Xinglong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.